Your Position: Home > Journal List > CHINA MEDICINE > Paper

The therapeutic effect of carvedilol for the treatment of essential hypertension

( views:, downloads: )
Author:
Chang Yifang()
Liu Yuesen()
Dong Aizhi()
Journal Title:
CHINA MEDICINE
Issue:
Volume 2, Issue 12, 2007
DOI:
Key Word:

Abstract:

  • [1]邢智敏,栾丽伟,邢智东,等.卡维地洛与非洛地平缓释片治疗难治性肾性高血压的疗效及安全性评价[J].中国医药,2007,2(11):677-678.
  • [2]黄燕.卡维地洛治疗慢性心力衰竭的临床研究[J].中国医药,2006,1(2):65-66.
  • [3]Rider PM,Vaughan DE,Stanpfer Mj,et al.Endogenous tissuetype Plasminogen activator and risk of myocardial infarction[J].Lancet,1993,34(1):1165-1169.
  • [4]Jarmon JH,Johansson B,Boman K,et al.Hypofibrinolysis patients with hypertension and elevated cholesterol[J].J Int Med,1999,98(1):229.
  • [5]Vaughan DE,Lazos SA,Tong K,et al.Angiotensin Ⅱ regulates expression of plasminogen activator inhibiter-1 in cultured endothelial eels[J].J Clin Invest,1995,95(2):995-998.
  • [6]Markh A,Goa KL.Valsartan,a review of its pharmacology and therapeutic use in essential hypertension[J].Drugs,1997,54(2):299-311.
  • [7]Emesto L,Jeong BP,Hope D,et al.Corporation of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan[J].Circulation,2000,101(14):1635-1659.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn